UPDATE: Citi Starts Amarin (AMRN) at Buy; Sees Favorable Risk/Reward Even if 'Going Alone' on Vascepa
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amarin Corp (AMRN) Receives U.S. Patent Covering Vascepa
November 27, 2012 7:31 AM ESTAmarin Corp Plc (NASDAQ: AMRN) that the U.S. Patent and Trademark Office (USPTO) has issued a patent covering Amarin's Vascepa® (icosapent ethyl) capsules based on U.S. Patent Application Serial No. 13/282,145. On September 4, 2012, Amarin announced the issuance of a Notice of Allowance for claims under this... More
Wedbush Comments on Amarin's (AMRN) Latest MARINE Family Notice of Allowance
November 26, 2012 1:04 PM ESTWedbush commented on Amarin Corporation (NASDAQ: AMRN) Monday afternoon in light of another Notice of Allowance to MARINE-family applications.
The firm notes today's '247 application is part of the MARINE methods-of-use family and claims the use of Vascepa without specifying use of other lipid lowering agents, such as statins. The '247 application appears to be closely related to the 775 application (13/608,775) for which Amarin announced... More
Amarin (AMRN) Announces Notification of Patent Allowance for U.S. Application
November 26, 2012 7:34 AM ESTAmarin Corporation plc (Nasdaq: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the United States Patent and Trademark Office (USPTO) has published notification of Notice of Allowance for U.S. Patent Application Serial Number 13/610,247. This application includes claims intended to protect the Vascepa® (icosapent ethyl) indication approved in July 2012 by the U.S. Food and Drug Administration (FDA) based on Amarin's MARINE clinical trial results.
The... More
